MIDWESTERN REPROCESSING CENTER REPROCESSED PULSE OXIMETER PROBE
K101280 · Midwest Reprocessing Center, LLC · NLF · Oct 7, 2010 · Cardiovascular
Device Facts
Record ID
K101280
Device Name
MIDWESTERN REPROCESSING CENTER REPROCESSED PULSE OXIMETER PROBE
Applicant
Midwest Reprocessing Center, LLC
Product Code
NLF · Cardiovascular
Decision Date
Oct 7, 2010
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 870.2700
Device Class
Class 2
Intended Use
The MRC Reprocessed Pulse Oximeter sensors are used as a noninvasive method to provide continuous SpO2 monitoring and pulse rate monitoring. These devices are intended for prescription use.
Device Story
Reprocessed pulse oximeter sensors; non-invasive; provide continuous SpO2 and pulse rate monitoring. Device contains dual-wavelength LED and optical photodiode housed in adhesive pad. LED emits red and infrared light in alternate pulses; photodiode generates current based on light absorption of arterial hemoglobin. Oximeter instrument interprets photodiode output to display readings. Used in clinical settings; operated by healthcare professionals. Benefits include non-invasive monitoring without tissue penetration, electrical contact, or heat transfer.
Clinical Evidence
Clinical testing demonstrated that the reprocessed devices, when used with compatible pulse oximeter instruments, perform as intended and are safe and effective. Supporting evidence includes non-clinical functional testing, cleaning validation, and biocompatibility testing.
Technological Characteristics
Dual-wavelength LED and photodiode sensor; housed in adhesive pad; cable with pin connector. Operates via optical absorption of arterial hemoglobin. No tissue penetration, electrical contact, or heat transfer. Reprocessed device maintains original technological specifications of predicate sensors.
Indications for Use
Indicated for patients requiring continuous non-invasive SpO2 and pulse rate monitoring. Prescription use only.
Regulatory Classification
Identification
An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.
{0}------------------------------------------------
OCT - 7 2010
.
| | 510K Summary | K101280 |
|--|--------------|---------|
|--|--------------|---------|
| Submitter: | Midwestern Reprocessing Center, LLC<br>3995 Fashion Square Blvd. Suite 11<br>Saginaw, MI 48603<br>Phone: (989) 583-4623<br>Fax: (989) 583-4633 |
|-------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact: | Jerome James<br>Consultant<br>Phone: (205) 314-3920<br>Fax: (205) 314-3959<br>Email: jerry.james@hygia.net |
| Date: | May 3, 2010 |
| Trade or<br>Proprietary Name: | Midwestern Reprocessing Center Reprocessed Sensors |
| Common Name: | Oximeter, Reprocessed |
| Classification: | 21 CFR 870-2700-Oximeter<br>NLF |
| Equivalent Device: | Corresponding Masimo LNCS, Nellcor OxiMax, and Nellcor<br>Oxisensor II Pulse Oximeter Sensors and Hygia Health Services<br>Reprocessed Pulse Oximeter Sensors legally marketed under various<br>510(k) premarket notifications. |
| | Masimo 510(k) K041815<br>Masimo 510(k) K051212<br>Hygia Health Services 510(k) K080424<br>Hygia Health Services 510(k) K041867<br>Nellcor Puritan Bennett, Inc. 510(k) K012891<br>Nellcor Puritan Bennett, Inc. 510(k) K863784<br>Hygia Health Services 510(k) K012715 |
| Device Description: | The Midwestern Reprocessing Center reprocessed pulse oximeter<br>sensors are non-invasive sensors used to provide continuous SpO2<br>monitoring and pulse rate. The sensors contain a dual wavelength<br>light emitting diode (LED), and an optical photodiode sensor which<br>are housed in a pad which attaches to the patient using adhesive<br>material. The LED emits red and infrared light in alternate pulses, |
{1}------------------------------------------------
## 510K Summary of Safety & Effectiveness (Con't)
## governed by the Oximeter instrument. The photodiode sensor responds to the light and generates a current that is interpreted by the Oximeter instrument. The Oximeter instrument interprets the different amounts of each light type (red and infrared) from the output of the photodiode and interprets the information and displays a reading. The sensor operates without any type of tissue penetration, electrical contact, or heat transfer to the patient. The sensors use optical means to determine the light absorption of functional arterial hemoglobin. The sensor is indicated for use as a non-invasive method to provide Indications for Use: continuous SpO2 monitoring and pulse rate. Technological The predicate devices and the MRC reprocessed device contain dual Characteristics: wavelength LED and a photodiode. The LED and photodiode are encased in a pad which attaches to the patient using adhesive material. The sensors are connected to a cable and they terminate in a pin connector. Biocompatibility and performance/functional testing demonstrate that the devices are equivalent to their predicate devices Functional testing, cleaning validation, and biocompatibility testing Testing: demonstrates that the reprocessed devices perform as intended and are safe and effective. Clinical Testing demonstrated that the reprocessed devices used with its compatible pulse oximeter perform as intended and are safe and effective. Based on the assessment of clinical testing, non-clinical functional Conclusion: testing, cleaning validation, and biocompatibility testing performed, Midwestern Reprocessing Center concludes that the Midwestern Reprocessing Center reprocessed pulse Oximeter sensors are substantially equivalent to their predicate devices ..
3-3
{2}------------------------------------------------
## DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Midwest Reprocessing Center LLC C/O Mr. Jerome James Hygia Health Services, Incorporated 434 Industrial Lane Birmingham, Alabama 35211
Re: K101280
Trade/Device Name: MRC Reprocessed Sensors Regulation Number: 21 CFR 870.2700 Regulation Name: Reprocessed Oximeter Regulatory Class: II Product Code: NLF Dated: September 29, 2010 Received: October 1, 2010
Dear Mr. James:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.
Image /page/2/Picture/9 description: The image is a blank white square. There are no objects or figures in the image. The image does not contain any text. The image is completely white.
QCT - 7 2010
{3}------------------------------------------------
Page 2- Mr. James
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
for
Anthony D. Watson, B.S., M.S., M.B.A. Director
Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
## Indications For Use
111280 OCT - 7 2010
| Applicant: | Midwestern Reprocessing Center, LLC (MRC) |
|--------------|-------------------------------------------|
| 510 (k): | K |
| Device Name: | MRC Reprocessed Sensors |
Indications for Use:
The MRC Reprocessed Pulse Oximeter sensors are used as a noninvasive method to provide continuous SpO2 monitoring and pulse rate monitoring.
These devices are intended for prescription use.
L. Schattner
(Division Sign-Off) (Division Sign-Off)
Division of Anesthesiology, General Hospital Division Control, Dental Devices
510(k) Number: K101280
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.